MEDICAL TESTING NEURODEGENERATIVE DISORDERS

Brand Owner (click to sort) Address Description
AUT ONE Cutaneous Neurodiagnostics 5070 North 40th St Suite 220 Phoenix AZ 85018 Medical testing for neurodegenerative disorders and other diagnostic or treatment purposes; Providing collected and analyzed medical information for diagnostic and treatment purposes for neurodegenerative disorders; Health assessment services, namely, performing quantitative neuropathological assessments of sensory, motor, and/or autonomic nerve fiber density; Health assessment services, namely, providing a pathological test for a diagnosis of synucleinopathy; Diagnostic services, namely, medical diagnostic testing for neurodegenerative disorders; Medical diagnostic testing, monitoring and reporting services; Providing medical data and information to healthcare professionals; Providing medical information to medical professionals in the form of reports in the field of neurological disorders;
SMALL FIBER DX CND Life Sciences, Inc. 5070 North 40th St Suite 220 Phoenix AZ 85018 Medical testing for neurodegenerative disorders and other diagnostic or treatment purposes; Providing collected and analyzed medical information for diagnostic and treatment purposes for neurodegenerative disorders; Performing quantitative neuropathological assessments of sensory, motor, and/or autonomic nerve fiber density; Providing a pathological test for a diagnosis of synucleinopathy; Diagnostic services, namely, medical diagnostic testing for neurodegenerative disorders; Medical diagnostic testing, monitoring and reporting services; Providing medical data and information to healthcare professionals; Providing medical information to medical professionals in the form of reports in the field of neurological disorders; Diagnostic preparations for skin biopsies for clinical or medical laboratory use; Diagnostic kits consisting of buffers and reagents for use in testing of neurodegenerative disorders;SMALL;
SYN ONE Cutaneous Neurodiagnostics 5070 North 40th St Suite 220 Phoenix AZ 85018 Medical testing for neurodegenerative disorders and other diagnostic or treatment purposes; Providing collected and analyzed medical information for diagnostic and treatment purposes for neurodegenerative disorders; Performing quantitative neuropathological assessments of sensory, motor, and/or autonomic nerve fiber density; Providing a pathological test for a diagnosis of synucleinopathy; Diagnostic services, namely, medical diagnostic testing for neurodegenerative disorders;
SYN QUIC Cutaneous Neurodiagnostics 5070 North 40th St Suite 220 Phoenix AZ 85018 Medical testing for neurodegenerative disorders and other diagnostic or treatment purposes; Providing collected and analyzed medical information for diagnostic and treatment purposes for neurodegenerative disorders; Health assessment services, namely, performing quantitative neuropathological assessments of sensory, motor, and/or autonomic nerve fiber density; Health assessment services, namely, providing a pathological test for a diagnosis of synucleinopathy; Diagnostic services, namely, medical diagnostic testing for neurodegenerative disorders; Medical diagnostic testing, monitoring and reporting services; Providing medical data and information to healthcare professionals; Providing medical information to medical professionals in the form of reports in the field of neurological disorders;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The present invention relates to a series of novel substituted 5-alkynyl pyrimidines, pharmaceutical compositions which contain them, methods for their preparation, and their use in therapy, particularly in the treatment of neurodegenerative or other neurological disorders of the central and peripheral nervous systems, including age related cognitive disorders such as senility and Alzheimer's disease, nerve injuries, peripheral neuropathies, and seizure disorders such as epilepsy.